Merquity Partners is led by a practicing surgeon and a finance & strategy advisor, bringing clients a rare combination of frontline clinical experience and institutional deal-making discipline.
A surgeon who trained at McKinsey. A dealmaker who has closed transactions for private equity. On the same engagement, clients get clinical judgment and financial firepower that usually require two separate firms, without the gap in between.
Double Board-Certified, General Surgery & Surgical Critical Care · Assistant Professor of Surgery, Medical University of South Carolina · Fellow, American College of Surgeons · Fellow, International College of Surgeons
Dr. Mallah is a double board-certified surgeon who has performed over 4,000 cases across five continents, ranging from academic medical centers to United Nations disaster relief zones, and serves as an Assistant Professor of Surgery at the Medical University of South Carolina. Prior to returning to full-time practice, he spent three years as a management consultant with McKinsey & Company, advising C-suite executives and government ministers on healthcare strategy, operations, and market entry.
Beyond his clinical and institutional expertise, Dr. Mallah understands the operational realities of scaling in resource-constrained environments. Having founded a successful grassroots venture and invented a patent-pending medical device, he knows firsthand what it takes to navigate regulatory pathways, optimize clinical workflows, and drive growth for independent healthcare organizations doing more with less.
Teaching penetrating abdominal trauma to the next generation of surgeons.
Presenting at the EAST Annual Scientific Assembly.
MBA, Simon Business School, University of Rochester · LLM, International Business Law, University of Dundee
Masih leads Merquity's financial, valuation, and transaction advisory practice, drawing on a global career bridging private equity, M&A, and strategy consulting across New York, London, and Dubai. He has evaluated and executed over $150M in M&A and investment opportunities within the healthcare, pharmaceutical, and technology sectors, consistently structuring deals and growth strategies that yield a 25–30% average IRR.
Having worked extensively with small and growing businesses on both the buy-side and sell-side, Masih understands the operational pain points of owner-operators. From guiding bolt-on acquisitions and driving organic marketing growth to navigating post-merger integrations, he delivers the institutional financial firepower needed to build enterprise value and secure strong exits.
Every engagement draws on both founders, no hand-offs, no re-explaining your business to a new team.
Book a Free 30-Minute Call →